Showing 12,241 - 12,260 results of 122,261 for search '(( 2 e decrease ) OR ( 5 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.12s Refine Results
  1. 12241
  2. 12242
  3. 12243

    Subcellular fractionation: opposite Effects of E2 and Pg on Cdh1 protein levels compared to p27, p-p27(T187), Skp2, and Cks1; Pg induces binding of Cdh1 to APC. by Kuang-Tzu Huang (132734)

    Published 2012
    “…The <i>inset in A</i> shows that lactacystin decreases Skp2 protein levels. C., Pg, Cdh1 binding to APC: Cells were treated with Pg/E2, cell lysates immunoprecipitated with anti-Cdh1 followed by immunoblotting with anti-Cdc27, as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0046072#s4" target="_blank">Materials and Methods</a>. …”
  4. 12244
  5. 12245
  6. 12246
  7. 12247

    A Series of Weak Ferromagnets Based on a Chromium–Acetylide–TTF Type Complex: Correlation of the Structures and Magnetic Properties and Origin of the Weak Ferromagnetism by Junichi Nishijo (1882738)

    Published 2013
    “…Magnetic measurements of the salts revealed that the weak ferromagnetic transition temperature gradually increases from 14.5 to 26.0 K as the interchain distance decreases from 3.997(2) to 3.803(2) Å, while the remanent magnetization at 2 K decreases from 0.0215 to 0.0079 μ<sub>B</sub>. …”
  8. 12248
  9. 12249

    TREM-B1 crosslinking reduces CLEC-2 induced thrombocyte degranulation. by Vanessa Turowski (3180918)

    Published 2016
    “…<p>(A) Co-crosslinking of CLEC-2 and TREM-B1 with the thrombocyte specific mab 8G8 and 1E9 decreased degranulation (lower panels) compared to co-crosslinking an irrelevant antibody and 8G8 (upper panels). …”
  10. 12250
  11. 12251
  12. 12252
  13. 12253

    Downstream molecular effects of knockdown or overexpression of eEF-2K in MDA-MB-231 cells. by Ibrahim Tekedereli (149655)

    Published 2012
    “…(<b>A–B</b>) Knockdown of eEF-2K by siRNA increases expression levels of p27<sup>Kip1</sup> (A), while decreasing cyclin D1 (A) and c-Myc (B) levels. …”
  14. 12254

    Comparison of Cyclic and Linear PEG Conjugates by Grace E. Kunkel (18630873)

    Published 2024
    “…Here, we report the first bioconjugation of a cyclic polymer, poly­(ethylene glycol) (PEG), to a model protein, T4 lysozyme, containing a single engineered cysteine residue (V131C). …”
  15. 12255

    Comparison of Cyclic and Linear PEG Conjugates by Grace E. Kunkel (18630873)

    Published 2024
    “…Here, we report the first bioconjugation of a cyclic polymer, poly­(ethylene glycol) (PEG), to a model protein, T4 lysozyme, containing a single engineered cysteine residue (V131C). …”
  16. 12256
  17. 12257

    Individual data 2020. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  18. 12258

    Household data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  19. 12259

    Persons with epilepsy data 2022. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”
  20. 12260

    Ivermectin coverage in 2019 and 2021. by Luís-Jorge Amaral (16406704)

    Published 2024
    “…Similarly, pNS incidence per 100,000 person-years decreased from 151.7 (95% CI: 112.7–203.4) to 27.0 (95% CI: 12.5–55.5). …”